Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Article in English | MEDLINE | ID: mdl-36313970

ABSTRACT

Objective: An increase in measles cases was reported in the north-western of the Lao People's Democratic Republic beginning in January 2019, with outbreaks quickly spreading throughout the country. Following identification of two laboratory-confirmed cases in Xaisomboun Province, we conducted an outbreak investigation to identify factors contributing to the measles outbreak in hard-to-reach Village X. Methods: Active case-finding was undertaken at the provincial hospital and primary health care centre via a retrospective search through admission logbooks and house-to-house surveys in Village X and surrounding villages. Clinical samples were collected from suspected cases, and data were collected using a standard case investigation form. Vaccine coverage data were reviewed. Results: Of the 40 suspected measles cases with rash onset during 12 February-27 April 2019, 83% (33/40) resided in Village X and 98% (39/40) were of Hmong-Lu Mien ethnicity. Ages ranged from 22 days to 5 years, with 70% (28) aged < 24 months. Almost half of cases aged 9 to < 18 months (5/11) and 67% (8/12) of cases aged 324 months had received a measles-containing vaccine (MCV). Reported MCV coverage in Xaisomboun for children aged < 1 year in 2017-2018 was < 50%. In 55% (22/40) of cases, case notification was delayed by 36 days. The final case classification comprised 10% laboratory-confirmed, 20% clinically compatible, 60% epidemiologically linked and 10% non-cases. Discussion: This measles outbreak was likely associated with low immunization coverage, compounded by delays in reporting. Effective strategies are needed to address beliefs about and health literacy barriers to immunization and measles awareness. Such strategies may improve MCV coverage and early diagnosis, enabling timely public health interventions and reducing mortality and morbidity.


Subject(s)
Measles , Child , Humans , Infant , Infant, Newborn , Retrospective Studies , Laos/epidemiology , Measles/epidemiology , Measles/prevention & control , Measles Vaccine , Disease Outbreaks/prevention & control , Vaccination
2.
J Clin Virol ; 54(2): 168-73, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22459002

ABSTRACT

BACKGROUND: Prompt and accurate laboratory diagnosis of measles is essential for case detection, outbreak management and ongoing surveillance in low incidence countries. Several disease markers are employed for diagnosis and are important to determine epidemiological and molecular characteristics for future control measures. OBJECTIVES: To report different disease markers, genotypes and epidemiology of a measles outbreak in Australia, a low incidence country. STUDY DESIGN: A retrospective descriptive study of the clinical and epidemiological features and laboratory diagnosis in 16 confirmed measles cases using measles serum IgM/IgG, antigen detection (IFA), viral RNA detection by real-time PCR and genotyping results for respiratory and urine specimens processed in one reference laboratory. RESULTS: Of the 16 confirmed measles cases, 11 were young adults aged between 20-35 years and 15 were not age-appropriately vaccinated. The most common genotype detected was D9 (11/16), followed by D4 (1/16) and D8 (1/16). Two imported cases were from the Philippines (D4) and Italy (D9). Of six disease markers, respiratory swab PCR and serum IgM gave the highest percentage (100%) of positive samples for confirmed cases followed by urine PCR (90.9%), serum PCR (66.6%), urine IFA (54.5%) and respiratory IFA (46.2%). CONCLUSIONS: Measles should be considered in the differential diagnosis of a presentation with fever and rash, even in countries in the elimination phase of measles control. Genotyping is a powerful molecular-epidemiological tool to assist low incidence countries towards eradication goals. Improving vaccination coverage remains essential, particularly in young adults and travellers.


Subject(s)
Antibodies, Viral/blood , Clinical Laboratory Techniques/methods , Disease Outbreaks , Measles virus/classification , Measles/epidemiology , Measles/virology , Adolescent , Adult , Australia/epidemiology , Child , Child, Preschool , Female , Genotype , Humans , Immunoglobulin G/blood , Immunoglobulin M/blood , Incidence , Infant , Male , Measles/pathology , Measles virus/genetics , Measles virus/isolation & purification , Molecular Epidemiology , Molecular Sequence Data , Retrospective Studies , Sequence Analysis, DNA , Young Adult
3.
N S W Public Health Bull ; 21(1-2): 10-5, 2010.
Article in English | MEDLINE | ID: mdl-20374688

ABSTRACT

During the DELAY and CONTAIN phases of pandemic (H1N1) 2009 influenza in NSW, public health units needed to rapidly surge operations to manage the 3070 potential cases and 1894 contacts notified to them. The Incident Control System, NetEpi (the web-based multi-user access database), training to up-skill surge staff, and electronic communication were all integral to the outbreak response. Ongoing identification and training of surge staff would assist a timely and effective response to future large scale outbreaks. Investing and incorporating information technology tools into routine public health unit business to assist with communication, outbreak management and reporting will improve familiarity and capability within the network to respond to public health emergencies.


Subject(s)
Disease Outbreaks , Influenza A Virus, H1N1 Subtype , Influenza, Human/epidemiology , Influenza, Human/prevention & control , Public Health Practice , Quarantine , Communicable Disease Control/organization & administration , Communication , Health Planning , Humans , Internet , New South Wales/epidemiology , Patient Isolation , Population Surveillance
4.
Med J Aust ; 185(9): 490-4, 2006 Nov 06.
Article in English | MEDLINE | ID: mdl-17137453

ABSTRACT

OBJECTIVE: To investigate the effectiveness of the Northern Territory Women's Cancer Prevention Program in improving cervical screening participation for Indigenous women. DESIGN: Descriptive longitudinal period prevalence study. PARTICIPANTS: All NT resident women aged 20-69 years who had at least one Pap smear recorded on the NT Pap Smear Register between 1997 and 2004. MAIN OUTCOME MEASURES: Indirectly estimated percentage of NT Indigenous women in rural and remote areas with a predominantly Indigenous population (accounting for 55% of the NT Indigenous population) who participated in screening, in biennial periods between 1997 and 2004. Participation by all eligible NT women (both Indigenous and non-Indigenous) is also reported by region for the same period. RESULTS: In 1997-1998, estimated participation for Indigenous women was about half the national rate (33.9% [95% CI, 32.6%-35.2%] v 63.9% [95% CI, 63.8%-63.9%]). Participation increased to 44.0% (95% CI, 42.7%-45.4%) in 1999-2000, and changed little thereafter; participation was higher in the Top End compared with Central Australia, and varied from 16.6% to 75.0% between remote areas. Participation rates for all women living in rural/remote regions were lower than those in urban regions. CONCLUSIONS: Recruitment of Indigenous women for cervical screening has improved since 1999. This may have partly contributed to the fall in their cervical cancer incidence and mortality in recent years. Although in most areas Indigenous participation is lower than national levels, in one area it was considerably higher. Improvements can be achieved by learning from these communities, to further close the gap in morbidity and mortality between Indigenous and non-Indigenous women.


Subject(s)
Health Policy , Mass Screening , Native Hawaiian or Other Pacific Islander/psychology , Patient Acceptance of Health Care/statistics & numerical data , Uterine Cervical Neoplasms/diagnosis , Adult , Aged , Female , Humans , Incidence , Longitudinal Studies , Middle Aged , Native Hawaiian or Other Pacific Islander/statistics & numerical data , Northern Territory/epidemiology , Retrospective Studies , Rural Health/statistics & numerical data , Uterine Cervical Neoplasms/epidemiology
5.
J Paediatr Child Health ; 42(12): 775-80, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17096712

ABSTRACT

AIM: To document the burden of disease caused by an outbreak of rotavirus (RV) gastroenteritis in a remote Aboriginal community. METHODS: During an outbreak of RV gastroenteritis, data were collected from patients notes, hospital and laboratory data. Age, date of presentation, severity of illness, number of total presentations, presentations per patient, total clinic hours per presentation, stool analysis, treatment and outcomes were measured. These data were compared with a time period of equal duration in order to establish a baseline burden of gastroenteritis. RESULTS: In a remote Aboriginal community 26 patients were managed for acute diarrhoea between 19 September 2005 and 5 October 2005. Gastroenteritis was the diagnosis in 24 cases for which there were 55 presentations. Stool specimens were analysed in 14 (58%) cases. RV was identified in eight (57%) of these specimens. The majority (80%) had mild disease. Moderate disease was noted in 15% and 5% were follow-up reviews. There were no severe cases of gastroenteritis. Four patients required evacuation to hospital. From a total of 607 presentations to the clinic during this time period, 55 (9%) were managed for acute diarrhoea. In the comparative time period there were five (0.9%) cases of acute diarrhoea from a total of 571 presentations. CONCLUSION: Rotavirus gastroenteritis places a large burden on remote Aboriginal communities and health-care centres in the form of morbidity, overworked clinic staff, economic cost and reduced capacity for primary health-care duties.


Subject(s)
Gastroenteritis/epidemiology , Rotavirus Infections/epidemiology , Adolescent , Adult , Australia/epidemiology , Australia/ethnology , Child , Diarrhea/epidemiology , Disease Outbreaks , Gastroenteritis/economics , Humans , Infant , Infant, Newborn , Middle Aged , Native Hawaiian or Other Pacific Islander , Rotavirus Infections/economics , Rotavirus Infections/etiology
6.
Aust N Z J Public Health ; 29(6): 521-5, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16366062

ABSTRACT

OBJECTIVE: To assess specific performance indicators relating to a register-based acute rheumatic fever and rheumatic heart disease (ARF/RHD) prevention program in a remote Australian Aboriginal community in order to identify the most appropriate avenues for improvements in delivery of services. METHODS: Information kept on the central ARF/RHD register was compared with an amalgamated dataset from three other sources. The community clinic charts of identified patients were reviewed for information regarding accuracy of diagnosis and the number of doses of benzathine penicillin received in the last year. Specific follow-up arrangements were assessed and compared with practice guidelines. RESULTS: The central ARF/RHD register contained the names of 58 of the 72 (81%) people identified in the community as eligible for inclusion. Only 42% (22/52) of people receiving antibiotic prophylaxis had received 80% or more of the recommended doses in the previous year; service delivery was significantly better for females than males (p = 0.004). Individuals in priority category 1 (most severe disease) were found to be receiving follow-up and investigation according to guidelines. About half the people in categories 2 (moderate disease) and 3 (mild disease) had been inadequately investigated and/or missed out on follow-up appointments. CONCLUSIONS: The ARF/RHD prevention program in this large remote Aboriginal community is struggling to deliver services to a substantial proportion of people who require them. Specific interventions, especially those related to men's health, may be required to correct the problems.


Subject(s)
Native Hawaiian or Other Pacific Islander , Registries , Rheumatic Fever/prevention & control , Rheumatic Heart Disease/prevention & control , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/therapeutic use , Female , Humans , Male , Northern Territory , Penicillin G Benzathine/administration & dosage , Penicillin G Benzathine/therapeutic use , Rheumatic Fever/drug therapy , Rheumatic Heart Disease/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...